skip to Main Content
Illinois Panel Adds 4 Pain Conditions to Be Treated by Medical Marijuana

An Illinois advisory board voted Wednesday to add chronic pain syndrome and three other pain conditions to the list of illnesses that can be treated by marijuana in Illinois.

The state’s Medical Cannabis Advisory Board had expressed frustration last month when Gov. Bruce Rauner’s administration rejected its first 11 suggestions for expanding the list of medical conditions.

Board chair Dr. Leslie Mendoza Temple said Wednesday that she hopes the Rauner administration will have a different response to the latest round of suggestions after dispensaries start selling the drug, which will be later this month or in early November.

Until the budget impasse in Springfield is resolved, board member Dr. Eric Christoff said, “we’re in a holding pattern, and we will carry on with our work.” But he believes the Rauner administration and lawmakers will see when sales begin that marijuana is a revenue stream. The Illinois law established a 7 percent tax on marijuana sales.

“It’s a revenue stream that’s not a broad-based tax,” Christoff said before the meeting in suburban Chicago. [Read more from the Associated Press at the Springfield State Journal-Register]

This Post Has 0 Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

Recent Stories

How Private Equity Trumped Social Equity in State Cannabis Deal

Confidential documents obtained by THE CITY reveal how Chicago Atlantic Group became one of the biggest beneficiaries of the state’s legalization program. Last June, Gov. Kathy Hochul announced that a…

Tech glitch on 4/20 caused Missouri cannabis businesses to lose sales

April 20 is a day recognized globally for celebrating cannabis culture, but it’s also like the cannabis industry’s Black Friday. Dispensaries offer deals designed to inspire people to flood their stores…

Japan’s cannabis market growing rapidly amid regulatory shift

Japan’s cannabis market expanded sixfold over four years to Â¥24 billion ($154 million) in 2023, a trend that is expected to accelerate with the amendment in December of cannabis laws,…

Ispire Leads with a Focus on Safety and Innovation

Los Angeles-based Ispire Technologies (NASDAQ: ISPR) is a three-year-old company built on the foundation (and reputation) of a global enterprise with many years of experience as an ODM (original design…

More Categories

Back To Top
×Close search
Search